Sino Medical Sciences Technology Inc. (SHA:688108)

SHA:688108 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	89.69	47.29	1.5	-39.63	-162.38	-130.77
Depreciation & Amortization	71.61	73.99	78.16	62.81	63.17	65.41
Other Amortization	9.16	19.77	24.39	24.55	24.11	15.48
Loss (Gain) From Sale of Assets	0.03	-	-0.29	1.41	-0	-0.19
Asset Writedown & Restructuring Costs	9.41	0.07	0.09	0.14	2.22	0.08
Loss (Gain) From Sale of Investments	-0.08	-	-11.19	4.67	4.11	0.29
Provision & Write-off of Bad Debts	0.27	0.27	-0.43	-1.41	1.33	-0.54
Other Operating Activities	10.71	10.77	18.47	5.37	6.78	11.62
Change in Accounts Receivable	-9.04	-16.59	10.31	18.86	7.73	100.12
Change in Inventory	-1.15	4.14	18.7	-14.53	-18.38	-27.79
Change in Accounts Payable	-5.3	0.21	0.34	3.03	8.04	-59.48
Change in Other Net Operating Assets	-	0.99	3.27	7.62	-	-
Operating Cash Flow	203.58	161.87	131.24	56.84	-111.31	-60.13
Operating Cash Flow Growth	19.27%	23.34%	130.89%	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-33.85	-45.8	-70.02	-67.67	-110.76	-158.45
Sale of Property, Plant & Equipment	0.02	0.03	0.83	1.39	0.02	0.66
Cash Acquisitions	-	-	-20.35	-127.05	-	-25.84
Investment in Securities	-	-	-	-	21.19	-5
Other Investing Activities	0.08	-	0.07	0.29	0.62	2.04
Investing Cash Flow	-33.75	-45.77	-89.46	-193.04	-88.93	-186.59

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Short-Term Debt Issued	-	-	-	-	55.5	5
Long-Term Debt Issued	-	67.4	81	159.5	-	-
Total Debt Issued	142.94	67.4	81	159.5	55.5	5
Short-Term Debt Repaid	-	-	-	-	-25	-
Long-Term Debt Repaid	-	-119.4	-93.79	-44.68	-16.2	-14.4
Lease Payments	-13.02	-13.02	-17.74	-9.18	-16.2	-14.4
Total Debt Repaid	-195.85	-119.4	-93.79	-44.68	-41.2	-14.4
Net Debt Issued (Repaid)	-52.91	-52	-12.79	114.82	14.3	-9.4
Issuance of Common Stock	8.47	11.53	15.38	-	103.5	-
Common Dividends Paid	-3.58	-4.19	-4.11	-2.01	-0.94	-0.03
Other Financing Activities	-27.9	34.91	62.99	9.5	-	-
Financing Cash Flow	-75.92	-9.74	61.47	122.32	116.86	-9.43

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Foreign Exchange Rate Adjustments	-2.06	-1.64	-0.21	-0.9	-0.95	-0.75
Net Cash Flow	91.85	104.73	103.03	-14.78	-84.33	-256.91

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	169.73	116.07	61.22	-10.83	-222.07	-218.58
Free Cash Flow Growth	67.53%	89.59%	-	-	-	-
Free Cash Flow Margin	28.79%	22.09%	13.35%	-3.16%	-115.15%	-112.46%
Free Cash Flow Per Share	0.41	0.27	0.16	-0.03	-0.55	-0.54
Levered Free Cash Flow	100.17	81.95	95.15	-29.66	-162.62	-163.59
Unlevered Free Cash Flow	103.32	85.1	98.66	-27.31	-161.02	-162.22
Free Cash Flow After Leases	156.72	103.06	43.48	-20.01	-238.28	-232.99

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Income Tax Paid	56.28	53.15	29.68	22.67	-3.27	1.14
Change in Working Capital	12.76	9.71	20.55	-1.07	-50.64	-21.52

Data Source: S&P Global Market Intelligence Last updated: Aug 24, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 13, 2026

Data Sources Report a data error